The hair removal epilator market is growing as consumers seek convenient, long-lasting, and private at-home grooming solutions. The market was valued at USD 1.67 billion in 2024 and is projected to reach USD 2.5 billion by 2032, expanding at a CAGR of 5.16%.wiseguyreports Rising awareness of personal grooming, changing beauty standards, social-media influence, and demand for convenience are central growth drivers. Consumers increasingly prefer devices that allow them to manage hair removal at...

The ibuprofen arginine tablets market is expanding as consumers and healthcare providers seek pain-relief solutions with rapid action, convenient formats, and broad availability. The market was valued at approximately USD 800 million in 2024 and is projected to reach USD 1.5 billion by 2035, growing at a CAGR of 5.9%.wiseguyreports Ibuprofen arginine is an ibuprofen formulation positioned around enhanced solubility and faster absorption compared with conventional ibuprofen formulations. This...

The specialty pharmaceutical market is growing as the prevalence of cancer, autoimmune disorders, neurological conditions, rare diseases, and chronic illnesses increases worldwide. The market was valued at USD 252.78 billion in 2024 and is projected to reach USD 380 billion by 2032, expanding at a CAGR of 5.22%.wiseguyreports Specialty pharmaceuticals are generally used to treat complex, chronic, rare, or high-cost conditions that require specialized handling, monitoring, patient support, or...

The hospital bed for ICU market is expanding as healthcare providers invest in critical-care capacity, patient safety, chronic disease management, and modern hospital infrastructure. The market was valued at USD 3.11 billion in 2024 and is projected to reach USD 4.7 billion by 2032, growing at a CAGR of 5.31%.wiseguyreports The growing prevalence of cardiovascular disease, cancer, respiratory illness, and other chronic conditions is increasing demand for intensive-care services. An aging...

The gynecomastia treatment market is growing as awareness of the condition improves, social stigma declines, and more patients seek medical or aesthetic solutions. The market was valued at USD 8.7 billion in 2024 and is projected to reach USD 13.23 billion by 2032, expanding at a CAGR of 5.39%. Growth is supported by increasing prevalence linked to hormonal imbalances, obesity, aging, certain medications, and rising demand for cosmetic procedures.wiseguyreports Gynecomastia refers to...

The organic and natural tampons market is expanding as consumers increasingly seek menstrual-care products that align with health, transparency, comfort, and sustainability priorities. The market was valued at USD 1.96 billion in 2024 and is projected to reach USD 3.0 billion by 2032, registering a CAGR of 5.48%.wiseguyreports Conventional menstrual products often use synthetic fibers, plastic components, fragrances, or other additives. In contrast, organic and natural tampons are commonly...

Asia-Pacific is expected to be the fastest-growing region in the vonoprazan fumarate API market. Rising healthcare investment, growing awareness of acid-related disorders, large patient populations, and strong pharmaceutical manufacturing capabilities are driving regional momentum.marketresearchfuture India and China are central to this growth because they have well-developed generic-drug industries and increasing capacity for active pharmaceutical ingredient production. Companies in these...

Growth hormone therapy remains the dominant medication segment in the Prader Willi syndrome therapeutics market. Its longstanding role in addressing growth-related and body-composition concerns has made it an important part of treatment approaches, especially in pediatric care.marketresearchfuture The need for treatment often begins early. Children with Prader Willi syndrome may require multidisciplinary support that includes endocrinology, nutrition management, physical therapy, behavioral...

Asia-Pacific is expected to be the fastest-growing regional market for peptide therapeutics, with a projected CAGR of 13.8% through 2035. The region is benefiting from rising metabolic-disease prevalence, expanding healthcare infrastructure, growing pharmaceutical investment, and increasing contract-manufacturing capacity.marketresearchfuture China and India are particularly important because they combine large patient populations with growing life-sciences capabilities. Demand for diabetes,...

Long-acting formulations are a key growth driver in the GLP-1 drug market because they can reduce dosing frequency and improve treatment convenience. The report identifies long-acting products as the largest drug-type segment, representing approximately 57% of the market.marketresearchfuture Less frequent dosing is important in chronic disease management. Patients managing diabetes or obesity may need ongoing treatment support, so therapies designed around weekly or extended intervals can...

Hospitals and ambulatory surgical centers account for the largest end-user share in the India medical devices market because they manage large patient volumes and use a broad range of equipment for diagnosis, treatment, surgery, and monitoring. Clinics are expected to grow quickly as outpatient care becomes more important.marketresearchfuture Hospitals require imaging systems, surgical devices, cardiovascular technologies, orthopedic implants, laboratory equipment, intensive-care devices, and...

Laboratory automation is reshaping the India laboratory equipment market as diagnostic providers, pharmaceutical companies, research institutions, and hospitals seek to improve productivity, accuracy, and workflow consistency. Automation can help laboratories manage larger sample volumes while reducing manual handling and potential errors.marketresearchfuture Automated laboratory systems may include sample preparation platforms, centrifuges, robotic handling systems, digital analyzers, smart...